行业
显示 31-40 个结果(共 44 个结果)
-
Bladder Cancer Market in China
根据StrategyHelix, the bladder cancer market in China, 就体积而言, 预计复合年增长率为 3.1% 在分析期间 2021 到 2027.
-
Pancreatic Cancer Market in China
根据StrategyHelix的统计, the pancreatic cancer market in China, 就体积而言, 预计复合年增长率为 3.3% 在预测期内 (2021-2027).
-
Urothelial Cancer Market in China
根据StrategyHelix的统计, the urothelial cancer market in China, 就体积而言, 预计复合年增长率为 3.2% 从 2021 通过 2027.
-
Gastric Cancer Market in China
The gastric cancer market in China was estimated at 470 千单位 2020 并预计达到 579 千单位 2027, 复合年增长率为 3% 整个预测期内, 根据StrategyHelix.
-
Breast Cancer Market in China
根据StrategyHelix, the breast cancer market in China, 就体积而言, 预计复合年增长率为 1.2% 从 2021 通过 2027.
-
Non-small-cell Lung Carcinoma (NSCLC) 中国市场
在 3% 复合年增长率, the non-small-cell lung carcinoma (NSCLC) market in China is projected to reach 967 千单位 2027, 据数据和分析公司 StrategyHelix 称.
-
Nasopharyngeal Cancer Market in China
根据StrategyHelix的统计, the nasopharyngeal cancer market in China, 就体积而言, 预计复合年增长率为 1.2% 未来五年.
-
Head and Neck Cancer Market in China
The head and neck cancer market in China, 就体积而言, 预计复合年增长率为 1.7% 从 2021 通过 2027, 据数据和分析公司 StrategyHelix 称.
-
Oncology Drug Market in China
The oncology drug market in China is poised to grow at a CAGR of around 13.3% 在分析期间 2021 到 2027, 据数据和分析公司 StrategyHelix 称.